Honestly, I've been going through the scenarios here. Not much reason for the shorts to be worried nor much reason for anyone to be chasing it higher when nothing is expected until next year. Now maybe they finish that cuti trial earlier since they enrolled it quicker than expected but prob not likely. What else until next year? I think they're in an excellent position and next year will be fantastic, but nothing is expected until then. I'm moving some funds around in case it drops and will just nibble at it and add to my position leading up until next year.
Any other thoughts you or anyone else reading this have? Maybe news on their other drug candidates or something coming before next year that I overlooked?
News 
Market Data 
Discover 
